Skip to main content
Signal8
Reilly Kevin C profile photo

Kevin C. Reilly

CIK: 0001958127

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KESTRA MEDICAL TECHNOLOGIES, LTD. logo
KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • KESTRA MEDICAL TECHNOLOGIES, LTD. logo
    KMTS

    KESTRA MEDICAL TECHNOLOGIES, LTD.

    Sep 9, 2026
    Award(A)
    Direct
    7.2K shares-
  • KESTRA MEDICAL TECHNOLOGIES, LTD. logo
    KMTS

    KESTRA MEDICAL TECHNOLOGIES, LTD.

    Sep 8, 2026
    Sale(S)
    Direct
    2.9K shares at avg. $25.13$74K
  • KESTRA MEDICAL TECHNOLOGIES, LTD. logo
    KMTS

    KESTRA MEDICAL TECHNOLOGIES, LTD.

    Mar 11, 2026
    Award(A)
    Direct
    8.3K shares-

1-3 of 3

About Reilly Kevin C

Reilly Kevin C (SEC CIK 0001958127) files insider reports with the SEC as Director of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).

Signal8 holds 3 ownership filings by Reilly Kevin C (1 Form 3, 2 Form 4), filed between Mar 6, 2025 and Sep 10, 2026. Those filings report 3 transactions, from Mar 11, 2026 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Reilly Kevin C's filings is in NEW YORK, NY.

Recent filings by Reilly Kevin C

  • Sep 9, 2026: Grant or award of KMTS shares (Form 4, code A).
  • Sep 8, 2026: Open-market sale of KMTS shares (Form 4, code S).
  • Mar 11, 2026: Grant or award of KMTS shares (Form 4, code A).

Other insiders filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

How to read Form 4 transaction codes